Other languages Ginkgo Bioworks Holdings, Inc.

Equities

DNA

US37611X1000

Market Closed - Nyse Other stock markets 04:00:02 2024-04-19 pm EDT			After market 05:03:55 pm
0.8649 ^USD	-6.46%		0.863	-0.22%

Apr. 16	Il Granaio delle Idee and Ginkgo Bioworks Announces Strategic Collaboration to Optimize Sourdough Strains for Bakery Products	CI
Apr. 11	Transcript : Ginkgo Bioworks Holdings, Inc. Presents at Ginkgo's Annual Ferment Conference 2024, Apr-11-2024

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Il Granaio delle Idee and Ginkgo Bioworks Announces Strategic Collaboration to Optimize Sourdough Strains for Bakery Products	Apr. 16
Ginkgo Bioworks Acquires AgBiome's Platform Assets	Apr. 11
Ginkgo Bioworks Expands Research Partnership With Novo Nordisk	Apr. 10
Ginkgo Bioworks Partners With IdeeLab Biotechnology in Brazil	Apr. 08
IdeeLab Joins the Ginkgo Technology Network to Provide Agriculture Companies in Brazil with End-to-End Product Development & Manufacturing Service	Apr. 08
Ginkgo Bioworks, Prozomix Collaborate on Enzyme Development	Apr. 03
Prozomix and Ginkgo Bioworks Collaborate on Next-Gen Enzyme Development for Sustainable API Manufacturing	Apr. 03
Ginkgo Bioworks (NYSE: DNA) completed the acquisition of cell therapy platform assets of Modulus Therapeutics.	Apr. 01
Ginkgo Bioworks Awarded $6 Million DARPA Contract to Work on Cold-Weather Applications for Military and Commercial Use	Mar. 28
Ginkgo Bioworks Wins DARPA Funding to Produce Novel Proteins to Control Ice in Extreme Cold Weather Environments	Mar. 28
Ginkgo Bioworks, AQUA Cultured Foods to Support Fish-Free Seafood Production	Mar. 27
AQUA Cultured Foods Partners with Ginkgo Bioworks to Optimize Alt-Seafood Production	Mar. 27
Ginkgo Bioworks, Imagindairy to Develop Animal-Free Dairy Proteins	Mar. 26
Imagindairy and Ginkgo Bioworks Collaborate to Develop and Produce Animal-Free Non-Whey Dairy Proteins	Mar. 26
Ginkgo Bioworks Collaborating With Dutch Biotech ProteoNic to Extend Proteins Production, Genetic Therapies	Mar. 13
Ginkgo Bioworks Q4 Loss Widens, Revenue Declines; 2024 Revenue Guidance Set; Shares Slump After Hours	Feb. 29
Ginkgo Bioworks Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29
Ginkgo Bioworks Holdings, Inc. Provides Revenue Guidance for the Year 2024	Feb. 29
Ginkgo Bioworks Holdings, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 29
Ginkgo Bioworks Acquires Reverie Labs, Proof Diagnostics, Patch Biosciences	Feb. 28

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Ginkgo Bioworks Holdings, Inc.

Equities

DNA

US37611X1000

Other languages

Filters